Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
810.00
-9.00 (-1.10%)
Feb 21, 2025, 9:00 AM KST
-43.31%
Market Cap 160.03B
Revenue (ttm) 68.03B
Net Income (ttm) -141.77B
Shares Out 197.57M
EPS (ttm) -1,529.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 508,730
Average Volume 1,873,437
Open 819.00
Previous Close 819.00
Day's Range 800.00 - 835.00
52-Week Range 600.00 - 2,350.00
Beta -0.08
RSI 53.69
Earnings Date Mar 14, 2025

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira... [Read more]

Sector Healthcare
Founded 1960
Employees 377
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.